The Quiet Reason Women Aren’t Investing
From Flo’s data reckoning to capital pattern bias, this week’s insights unpack the hidden forces that shape who gets to invest and what gets funded.
This newsletter is 100% free. But it takes hours each week to research, write, and produce at this level. Here are 5 ways to support my work: 1. click “❤️” to amplify 2. subscribe 3. share this publication 4. buy me coffee 5. become a partner
📲 connect and collaborate with me here! email | LinkedIn | Instagram
Dear Reader,
This week, over coffee, a woman told me she had never invested. All her excess funds had been sitting in a savings account for decades. Not because she wasn’t interested but because no one had ever asked her to.
It was a quiet moment that stayed with me. Because that’s how capital gaps often begin: not with rejection, but with omission. No information. No invitation. No expectation.
This week’s dispatch tracks three places where that absence shows up and what it costs us.
Let’s get into it.
How History Locked Women Out of Investing
What if the so-called “risk aversion” among women investors isn’t a preference, but the result of decades of conditioning and structural exclusion? This piece rewires the lens on the gender investing gap.
Why Women Don’t Invest And Why That’s Changing Now
We were told to save. To be cautious. To wait. But that advice didn’t come from nowhere. It came from a system that never expected women to have capital, let alone move it. This is the story of how we got here and why the most powerful thing some of us will do is say: I’ll invest anyway.
Investors Reach for What They Recognize
At a recent conference, someone asked why women’s health remains so underfunded. I offered a simple answer in the Institutional Investor publication. Conviction drives capital but conviction is built on pattern recognition. That’s where innovation gets locked out.
When Femtech Gets Sued, But Tampon Safety Goes Under the Radar
A class-action lawsuit against Flo Health for data-sharing violations is back in the headlines. But where’s the scrutiny for legacy products that have never been tested for safety? This week’s Signal Not Noise brief unpacks how public narratives distort investor risk perception and where the real diligence should be.
Signal Not Noise: Flo’s Data Reckoning, Evvy’s Expansion & Toxic Tampons Wake Up the Market
From lawsuits to product launches, this week’s headlines reveal more than noise. They signal how women’s health is being redefined as a serious market. Here’s what investors should really be watching.
📣 Next Week...
I’ll be featuring a Swiss women’s health company doing credible, science-first work in a space long overlooked. One that isn’t trying to go viral but just trying to prove what works. Stay tuned.
👋 Ready to Learn How to Invest?
This September, I am opening a new cohort of the Investor Readiness Program; a 6-week, immersive course for women who want to confidently invest in health innovation.
No jargon. No hedge fund background required. Just the desire to understand how capital shapes change.
❤️ Enjoying this? If this post sparked something for you, click the ❤️ at the bottom. It helps more than you know and tells me you're reading.
Coming in July 2025:
🎧 Blindspot Capital: The Podcast
Formerly FemmeHealth Founders, our podcast relaunches this summer under a sharper lens and a bolder name. Blindspot Capital explores the undercurrents shaping health innovation from the deals that stall to the systems that silence. This season, we speak to the people shifting what gets seen, funded, and scaled.Confirmed guests include:
💥 Ida Tin (Clue, FemTech Assembly) on founding the femtech category
🧠 Lisa Suennen (venture partner & healthtech strategist) on how institutional capital moves.We are also in conversation with voices from maternal science to global policy stay tuned as the full season drops.
👉 Subscribe to Blindspot Capital wherever you get your podcasts, or listen directly on Substack.
I write weekly at FemmeHealth Ventures Alliance about capital, care, and the future of overlooked markets. If you are building, backing, or allocating in this space, I’d love to connect.
👉 ICYMI - Our Latest Publications
How to Use Your Roth IRA to Start Investing in Women’s Health
How to Start Angel Investing in Women’s Health with Just $1K
Why Women’s Health Is Still Underfunded and What Smart Investors Are Doing About it
The 1,000-Day Fix: Nina Kumari’s Case Against “Good Enough” Formula
Disclaimer & Disclosure
This content is for informational and educational purposes only. It does not constitute financial, investment, legal, or medical advice, or an offer to buy or sell any securities. Opinions expressed are those of the author and may not reflect the views of affiliated organisations. Readers should seek professional advice tailored to their individual circumstances before making investment decisions. Investing involves risk, including potential loss of principal. Past performance does not guarantee future results.
